| Literature DB >> 32224163 |
Ritesh Gupta1, Aanchal Gupta2, Mitu Shrikhande3, Kanika Tyagi2, Amerta Ghosh2, Anoop Misra4.
Abstract
SGLT-2 inhibitors are known to increase hematocrit. We present two cases with marked asymptomatic erythrocytosis developing after taking SGLT-2 inhibitors. No other predisposing or causative factor was found and SGLT-2 inhibitor drug was the most likely cause in both cases. Both patients underwent phlebotomy and haematocrit came down after withdrawing the offending drug.Entities:
Keywords: Eryhtrocytosis; Increased hematocrit; SGLT2 inhibitors
Year: 2020 PMID： 32224163 DOI： 10.1016/j.diabres.2020.108127
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN： 0168-8227 Impact factor: 5.602